|
biomedicina slovenica |
pr=Barbič-Žagar : 37
-
Soklič Tanja; Barbič-Žagar Breda; Debelak Tjaša
Učinek kombiniranega pršila s ksilometazolinom in z dekspantenolom (Septanazal) na nosno kongestijo po operativnem posegu v nosu in obnosnih votlinah
[Effect of xylometazoline and dexpanthenol combination nasal spray (Septanazal) on nasal congestion in patients after surgery in the nose and paranasal cavity]
2021 ►
-
Požlep Gorazd; Barbič-Žagar Breda; Marinšek Gašper; Plut Špela
Spremljanje učinkovitosti in varnosti zdravljenja pooperativne bolečine s kombinacijo tramadola in paracetamola
[Study on the efficacy and safety of a tramadol and paracetamol combination in patients with postoperatiave pain]
2020 ►
-
Jug Borut; Barbič-Žagar Breda; Grošelj Mateja; Milovanovič Jarh Darja; Lipušček Tjaša
Neintervencijsko spremljanje učinkovitosti in varnosti zdravljenja z rosuvastatinom (Sorvasta) in uvajanje dodatnih jakosti v klinično prakso pri bolnikih s hiperlipidemijo - FROZEN
[Non-interventional study of efficacy and safety of rosuvastatin (Sorvasta) therapy and introduction of additional strengths to clinical practice in patients with hyperlipidaemia - FROZEN]
2019 ►
-
Barbič-Žagar Breda; Debelak Tjaša; Čežina Anastasija; Herman Ana
Učinkovitost in varnost pastil z izvlečkom iz listov bršljana (35 mg) pri bolnikih z akutnim bronhitisom
[Efficacy and safety of ivy leaf extract 35 mg lozenges in patients with cough in acute bronchitis]
2020 ►
-
Petek Šter Marija; Barbič-Žagar Breda
Treatment of patients with arterial hypertension in family medicine in Slovenia - Assessment of the situation after the introduction of modal practices
[Obravnava bolnikov z arterijsko hipertenzijo v ambulantah družinske medicine v Sloveniji - Ocena stanja po uvedbi referenčnih ambulant]
2021 ►
-
Čelofiga Andreja; Barbič-Žagar Breda; Vrzel Marina; Meško Obretan Jasna
Učinkovitost in varnost duloksetina (Dulsevia) v odmerku po 90 mg v klinični praksi pri bolnikih z veliko depresivno motnjo ali generalizirano anksiozno motnjo
[Efficacy and safety of duloxetine (Dulsevia) in the dose of 90 mg in patients with major depressive disorder or generalized anxiety disorder in clinical practice]
2020 ►
-
Chazova Yevgenyevna Irina; Martynyuk Tetyana; Accetto Rok; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda; Arhipov M. V.; Grinshtein Y. I.; Ostroumova O. D.
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor%) and its fixed combination with hydrochlorothiazide (Valsacor% H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
2017 ►
-
Chazova Yevgenyevna Irina; Martynyuk Tetyana; Accetto Rok; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda; Arhipov M. V.; Grinshtein Y. I.; Ostroumova O. D.
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial
2018 ►
-
Accetto Rok; Chazova Yevgenyevna Irina; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda
The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension- the VICTORY trial
2017 ►
-
Accetto Rok; Widimský Jiří; Vincelj Josip; Sirenko Yuriy; Chazova Yevgenyevna Irina; Barbič-Žagar Breda
The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with ...
2018 ►
-
Krevel Barbara; Barbič-Žagar Breda; Uranič Nataša
Učinkovitost in varnost enega odmerka Flebavena (diosmin) po 1.000 mg dnevno pri bolnikih s kronično vensko boleznijo
[The Efficacy and safety of a daily 1.000 mg dose of Flebaven (diosmin) in patients with chronic venous disease]
2020 ►
-
Vasić Danijela; Novaković Marko; Božič Mojca; Barbič-Žagar Breda; Jug Borut
Short-term water- and land-based exercise training comparably improve exercise capacity and vascular function in patients after a recent coronary event
2019 ►
-
Barbič-Žagar Breda
Z dokazi podprto zdravljenje s Krkinimi izdelki
2014 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar Perme Maja; Stare Janez
Preprečevanje ishemičnih dogodkov pri bolnikih s periferno arterijsko boleznijo
2014 ►
-
Koprivšek Jure; Vrzel Marina; Barbič-Žagar Breda
Učinkovitost in varnost aripiprazola v zdravljenju shizofrenije in bipolarne motnje
[Efficacy and safety of aripiprazole in patients with shizophrenia and bipolar mania]
2017 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Stare Janez; Pohar Perme Maja
Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease
2017 ►
-
Rotar-Pavlič Danica; Kitak Teja; Barbič-Žagar Breda
Neintervencijsko spremljanje učinkovitosti in varnosti fiksne kombinacije perindoprila in amlodipina (Amlessa) v zdravljenju arterijske hipertenzije in vpliva dodatnih dejavnikov tveganja za srčno-žilne bolezni na bolnikovo zavzetost za zdravljenje (COMIPLANT)
[Post-authorization efficacy and safety study of treatment with fixed-dose combination of perindopril and amlodipine (Amlessa) in patients with arterial hypertension and the impact of additional risk factors for cardiovascular diseases on patient compliance (COMPLIANT)]
2016 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Alenka; Barbič-Žagar Breda; Pohar Perme Maja; Stare Janez
What to expect from prevention cardiovascular disease in patients with peripheral arterial disease
2015 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Alenka; Barbič-Žagar Breda; Pohar Perme Maja; Stare Jernej
Cardiovascular disease prevention in paients with peripheral arterial disease-results of a 5-year observational study
2014 ►
-
Blinc A; Kozak M; Šabovič M; Božič M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study
2011 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar-Perme Maja; Stare Janez
Is it possible to prevent CV events in PAD patients? (Results of PID-PAB study)
2011 ►
-
Bon Jurij; Barbič-Žagar Breda; Bevec Matevž
Neintervencijsko spremljanje učinkovitosti in varnosti olanzapina (Zolrix) v zdravljenju shizofrenije in bipolarne manije
[Post-authorization safety and efficacy study of olanzapine (Zolrix) in the treatment of shizophrenia and bipolar mania]
2011 ►
-
Blinc A; Kozak M; Šabovič M; Božič M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
Prevention of ischaemic events in patients with peripheral arterial disease according to the European guidelines on cardiovascular disease prevention in practice
2009 ►
-
Bedenčič M; Blinc A; Božič M; Stegnar M; Kozak M; Šabovič M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
Association of haemostatic and inflammatory markers with future ischemic cardiovascular events in patients with peripheral arterial disease - initial laboratory results of the prevention of ischemic events in patients with peripheral arterial disease (PID)
2009 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar-Perme Maja; Stare Janez
Slovenska raziskava o preprečevanju ishemičnih zapletov pri bolnikih s periferno arterijsko boleznijo - 2-letni rezultati raziskave PIB-PAB
2009 ►
-
Barbič-Žagar Breda; Ristovski Aleksandar; Dular-Meglič Tina
Ocena učinkovitosti, varnosti in sprejemljkivosti orodisperzibilnega risperidona pri bolnikih s shizofrenijo ali bipolarno manijo in pri vedenjskih motnjah dementnih bolnikov
[Evaluation of efficacy, safety and acceptability of orodispersible risperidone in patients with schizophrenia, bipolar mania and behavioural disturbances in dementia patients]
2008 ►
-
Barbič-Žagar Breda; Kos Jernej; Grošelj Mateja
Klinične izkušnje z atorvastatinom v visokih odmerkih
[Clinical experience with high doses of atorvastatin]
2007 ►
-
Blinc Aleš; Kozak Matija; Šabovič Mišo; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Stare Janez; Pohar-Perme Maja
Preprečevanje ishemičnih dogodkov pri bolnikih s periferno arterijsko boleznijo - raziskava PID-PAB: načrt raziskave, značilnosti preiskovancev ob vključitvi in delni rezultati po enem letu
2008 ►
-
Barbič-Žagar Breda
Učinkovitost in varnost Vasilipa pri bolnikih s hiperholesterolemijo
[The efficacy and safety of Vasilip in patients with hypercholesterolemia]
2002 ►
-
Barbič-Žagar Breda; Drinovec Jože
Predgovor
2002 ►
-
Mrhar Aleš; Barbič-Žagar Breda
Farmakoekonomski pogledi na zdravljenje s statini
2000 ►
-
Barbič-Žagar Breda
Medikamentno zdravljenje srčnega popuščanja
1999 ►
-
Barbič-Žagar B; Oblak D
Vloga zdravil pri preprečevanju bolezni srca in ožilja
1998 ►
-
Barbič-Žagar Breda
Pomen antihipertenzivnega zdravljenja s fiksnimi kombinacijami zdravil
1997 ►
-
Barbič-Žagar Breda
Nekateri farmakoekonomski pogledi na zdravljenje srčnega popuščanja
1997 ►
-
Barbič-Žagar Breda
Farmakoekonomski vidiki hipolipemičnih zdravil
[Pharmacoeconomic aspects of hypolipemic drugs]
1998 ►
-
Barbič-Žagar Breda
Mesto pentoksifilina pri kritični ishemiji udov
1997 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics